Please provide your email address to receive an email when new articles are posted on . The addition of high-flow nasal cannula to long-term oxygen therapy may ...
Patients at high risk for pulmonary complications had similar support needs at 90 days with HFNOT or standard oxygen.
In a large randomized trial, treating patients with acute hypoxemic respiratory failure with high-flow oxygen didn't improve survival compared with standard oxygen. However, high-flow oxygen did ...
MedPage Today on MSN
Increasingly Utilized Strategy After Cardiac Surgery Fails in Large Trial
High-flow nasal oxygen therapy didn't improve survival while maintaining functional indepe ...
No new safety concerns were identified with the use of high-flow oxygen therapy.
Data are needed on the effect of oxygen delivered through a high-flow nasal cannula, as compared with standard oxygen therapy, on intubation and mortality in patients with acute hypoxemic respiratory ...
Please provide your email address to receive an email when new articles are posted on . Children aged 1 to 4 years with acute hypoxemic respiratory failure did not experience shorter hospital stays on ...
IRVINE, Calif.--(BUSINESS WIRE)--Telesair, Inc., an innovator of next-generation respiratory care, and JPP Care, a leading Thai distributor of respiratory devices, jointly announced today that ...
High-flow oxygen didn't help patients survive acute hypoxemic respiratory failure better than standard oxygen, the SOHO trial showed. Mortality at day 28 came out an identical 14.6% in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results